A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase

Neuroleptic malignant syndrome (NMS) is a life-threatening adverse reaction to antipsychotic drugs. Although there is no specific examination able to diagnose NMS, serum creatine kinase (CK) elevation has been reported in over 90% of NMS patients. In this report, we describe a patient who developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Nisijima, Koichi, Shioda, Katutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938441/
https://www.ncbi.nlm.nih.gov/pubmed/24591835
http://dx.doi.org/10.2147/NDT.S58677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938441/
https://www.ncbi.nlm.nih.gov/pubmed/24591835
http://dx.doi.org/10.2147/NDT.S58677

Ejemplares similares